Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Inc.

www.pfizer.com

Latest From Pfizer Inc.

DOJ's Investigation Of Reckitt's Suboxone Promotions Marks The Return Of The Big Settlement

$1.4b payment to settle investigation of marketing of opioid addition treatment is biggest for a pharma in several years.

Advertising, Marketing & Sales Legal Issues

FTC's First Product Hopping Complaint Targets Safety Claims For Suboxone Film Formulation

Commission files complaint as it reaches $50m settlement with Reckitt Benckiser.

Legal Issues Enforcement

Impact Of Higher Part D Donut Hole Discounts Beginning To Show: Xarelto Sales Down 19%

Performance of Johnson & Johnson’s blockbuster cardiovascular drug is one of the first prominent examples of how the 2019 increase in the discount from 50% to 70% is playing out in the market.

Reimbursement Medicare

New Kisqali Combination Joins Verzenios In England’s Cancer Drugs Fund

Two of the three companies vying for an additional share of England’s CDK4/6 inhibitor market have now secured reimbursement for the use of their products in combination with fulvestrant for advanced breast cancer.
Reimbursement United Kingdom
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register